Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis.
Youssef SolimanMohamed AbuelazmBasma Ehab AmerMishaal HukamdadMohamed Hatem EllabbanNada Ibrahim HendiAdel MouffokesBasel AbdelAzeemHatem HassaballaPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
SGLT2i are associated with a reduced risk of AF recurrence after CA in patients with T2DM. These results suggest that SGLT2i is promising in improving clinical outcomes for this population.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- study protocol
- clinical trial
- percutaneous coronary intervention
- phase iii
- randomized controlled trial
- phase ii
- metabolic syndrome
- type diabetes
- skeletal muscle
- acute coronary syndrome
- mitral valve
- adipose tissue
- left ventricular
- weight loss
- protein kinase
- glycemic control